This Agreement considers Argentum’s service on exploring and identifying non-dilutive funding sources and preparing and filing award applications for research and development (or other similarly natured) funding opportunities (grants and contracts) from funding agencies including but not limited to U.S. Federal sources such as NIH, BARDA, and DOD and Private Foundations:
This Agreement considers Argentum’s service on exploring and identifying non-dilutive funding opportunities and preparing and filing applications for research and development funding opportunities (grants) from Funding Programs managed and funded by the European Union or by European and Associated Governments.
The CEO Dr. Neinar Seli and Professor Mati Karelson presented Chemestmed’s groundbreaking results on unique proprietary RNA m6A activators in neuroscience titled as “Neuroprotective agents based on RNA m6A regulation”
